Initial Statement of Beneficial Ownership

This filing is an Initial Statement of Beneficial Ownership (Form 3) for Wang Xu, CEO and Director of LakeShore Biopharma Co., Ltd. (LSB). Wang Xu has been granted share options to acquire 203,464 ordinary shares with an exercise price of $1.225 per share. The options vest starting December 31, 2024, with 25% vesting on that date and the remaining 75% vesting in three equal annual installments thereafter, contingent upon continued service. The options expire on December 13, 2034.